The Institute for Neurological Research®, a private medical group, inc (INR®). has invented and pioneered new therapeutic approaches for treatment of Alzheimer's Disease.

Anti-TNF treatment for Alzheimer's
Disclaimer: Individual results vary. Anti-TNF treatment for the indications below is off-label. Please see the Legal Disclaimer. Adverse reactions may occur. Some patients do not respond. Weekly maintenance dosing is necessary for optimal effect. The methods of anti-TNF treatment utilized for these patients are patented inventions of the INR.

The video below, available in different media formats, is an interview with a family member discussing the response to initiation of anti-TNF treatment at the INR. For the published results please see TNF-alpha Modulation for Treatment of Alzheimer's Disease: A 6-Month Pilot Study. Tobinick E, Gross H, Weinberger A, Cohen H. MedGenMed 2006; 8(2) :25 .
Video 2: TNF-alpha modulation for Alzheimer's Disease video length 3.5 minutes

(please note: the movie will begin to play after it is completely downloaded, which may take more than two minutes)
Launch in external player

Note: This is a medium download of 20mb. The treatment method depicted in this video is a patented invention of the INR, and is available exclusively at the INR.


Institute for Neurological Research, a private medical group, inc.
100 UCLA Medical Plaza, Suites 205-210 Los Angeles, California 90095

Appointments and Information: (310) 824-6199

Copyright ©2007, the Institute for Neurological Research® (INR®), a private medical group, inc. Methods of off-label use of certain anti-TNF biologics for treatment of selected neurological disorders, including Alzheimer's, are patented inventions of the INR; these methods are neither sponsored nor endorsed by UCLA; rather, all rights to these patented methods of treatment are retained exclusively by the INR. The INR conducts a private medical practice. U.S. patents 6015557, 6177077, 6419934, 6419944, 6471961, 6537549, 6982089, 7214658 and additional issued and pending U.S. and foreign patents.
Return to Home Page
<Alzheimer's><Referrals to the INR><Map and Directions><Appointments><Terms of Use><Publications><Dementia>